National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 60542 [05-20751]
Download as PDF
<![CDATA[
60542
Federal Register / Vol. 70, No. 200 / Tuesday, October 18, 2005 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Advisory Committee to the Director,
National Cancer Institute.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Advisory Committee
to the Director, National Cancer Institute.
Date: October 31, 2005.
Time: 11 a.m. to 11:45 a.m.
Agenda: The purpose of the meeting will
be to review the key Sarcoma PRG
recommendations.
Place: National Institutes of Health,
National Cancer Institute, 31 Center Drive,
Room 11A48, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Cherie Nichols, Director of
Science Planning and Assessment, National
Cancer Institute, National Institutes of
Health, Building 6116, Room 205, Bethesda,
MD 20892, (301) 496–5515.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/joint/htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: October 4, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–20755 Filed 10–17–05; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
17:22 Oct 17, 2005
Name of Committee: Sickle Cell Disease
Advisory Committee.
Date: November 7, 2005.
Time: 8:30 a.m. to 4 p.m.
Agenda: Discussion of Program policies
and issues.
Place: National Institutes of Health, 6701
Rockledge Drive, Room 9112, Bethesda, MD
20892.
Contact Person: Robert B. Moore, PhD,
Health Scientist Administrator, Blood
Diseases Program, Division of Blood Disease
and Resources, National Heart, Lung, and
Blood Institute, NIH, 6701 Rockledge Drive,
Room 10162, Bethesda, MD 20892, 301/435–
0050.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nhlbi.nih.gov/meetings/index.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS).
Dated: October 6, 2005.
Anthony M. Coelho, Jr.,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–20730 Filed 10–17–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4140–01–M
VerDate Aug<31>2005
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Sickle Cell Disease Advisory
Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Jkt 208001
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Review of Research Scientist Development
Awards (K01s).
Date: November 3–4, 2005.
Time: 6 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: St. Gregory Hotel, 2033 M Street,
NW., Washington, DC 20036.
Contact Person: Zoe Huang, MD, Health
Scientist Administrator, Review Branch,
Room 7190, Division of Extramural Affairs,
National Heaart, Lung, and Blood Institute,
6701 Rockledge Drive, Room 7190, Bethesda,
MD 20892–7924, 301–435–0314,
huangz@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Innovative Technologies for Engineering
Small Blood Vessels.
Date: November 9, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Columbia Hotel, 10207
Wincopin Circle, Columbia, MD 21044.
Contact Person: David A. Wilson, PhD,
Scientific Review Administrator, Division of
Extramural Affairs, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6701 Rockledge Drive, Room 7204, MSC
7924, Bethesda, MD 20892, 301/435–0929.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Review of Research Program Project
Applications (PO1s).
Date: November 14, 2005.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Columbia Hotel, 10207
Wincopin Circle, Columbia, MD 21044.
Contact Person: Valerie L. Prenger, PhD,
Scientific Review Administrator, Division of
Extramural Affairs, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7214, Bethesda, MD 20892–7924, (301) 435–
0270. prengerv@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: October 3, 2005.
Anthony M. Coelho, Jr.
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–20751 Filed 10–17–05; 8:45 am]
BILLING CODE 4140–01–M
E:\FR\FM\18OCN1.SGM
18OCN1
]]>Agencies
[Federal Register Volume 70, Number 200 (Tuesday, October 18, 2005)]
[Notices]
[Page 60542]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-20751]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel, Review of Research Scientist Development
Awards (K01s).
Date: November 3-4, 2005.
Time: 6 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: St. Gregory Hotel, 2033 M Street, NW., Washington, DC
20036.
Contact Person: Zoe Huang, MD, Health Scientist Administrator,
Review Branch, Room 7190, Division of Extramural Affairs, National
Heaart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7190,
Bethesda, MD 20892-7924, 301-435-0314, huangz@nih.gov.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel, Innovative Technologies for Engineering
Small Blood Vessels.
Date: November 9, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton Columbia Hotel, 10207 Wincopin Circle, Columbia,
MD 21044.
Contact Person: David A. Wilson, PhD, Scientific Review
Administrator, Division of Extramural Affairs, National Heart, Lung,
and Blood Institute, National Institutes of Health, 6701 Rockledge
Drive, Room 7204, MSC 7924, Bethesda, MD 20892, 301/435-0929.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel, Review of Research Program Project
Applications (PO1s).
Date: November 14, 2005.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton Columbia Hotel, 10207 Wincopin Circle, Columbia,
MD 21044.
Contact Person: Valerie L. Prenger, PhD, Scientific Review
Administrator, Division of Extramural Affairs, National Heart, Lung,
and Blood Institute, 6701 Rockledge Drive, Room 7214, Bethesda, MD
20892-7924, (301) 435-0270. prengerv@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: October 3, 2005.
Anthony M. Coelho, Jr.
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-20751 Filed 10-17-05; 8:45 am]
BILLING CODE 4140-01-M
